BSE filing, NSE: GOPALA. Summary written from the filing by ALFA Finder's alert engine.
HCP Plastene Bulkpack Ltd: key numbers
- Share price
- ₹310.40
- Market cap
- ₹331.4 Cr
- Revenue (annual)
- ₹587.5 Cr
- Net profit (annual)
- ₹23.20 Cr
- P/E (TTM)
- 10.0×Sector 43.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 3.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HCP Plastene Bulkpack Ltd
All →HCP Plastene Bulkpack Other Announcement
HCP Plastene Bulkpack Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides the company's equity distribution across various categories.
HCP Plastene Bulkpack Management Change
The Board appointed Mr. Prakash Hiralal Parekh as CFO of the company. Additionally, M/s. Nirav Patel & Associates was appointed as the new internal auditor.
HCP Plastene Bulkpack Annual General Meeting
HCP Plastene Bulkpack Limited concluded its 42nd Annual General Meeting on September 25, 2026. Shareholders approved all resolutions including re-appointments and increasing borrowing limits to Rs. 500 Crore.
HCP Plastene Bulkpack Annual Report
HCP Plastene Bulkpack Limited has filed its Annual Report for the financial year 2025-2026. This submission includes the notice for the upcoming 42nd Annual General Meeting.
HCP Plastene Bulkpack Other Announcement
HCP Plastene Bulkpack Limited is dispatching a letter with the web-link for its 42nd Annual Report to shareholders with unregistered email addresses for regulatory compliance.
HCP Plastene Bulkpack Annual General Meeting
HCP Plastene Bulkpack Limited announced its 42nd Annual General Meeting scheduled for September 25, 2026. The meeting will address financial adoption and related party transactions.
Other employee stock options announcements
All →Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Coforge Employee Stock Options
Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.
Greenply Industries Employee Stock Options
Greenply Industries allotted 500 equity shares under its ESOP 2020 scheme on 29 October 2026. The allotment lifts paid-up capital to Rs.12,49,02,545.
Firstsource Solutions Employee Stock Options
Firstsource's Nomination and Remuneration Committee approved a grant of 587,750 stock options to eligible employees. The grant falls under its 2019 Employee Stock Option Plan.
Vedanta Power Employee Stock Options
Vedanta Power granted 78,11,356 ESOP stock options under VPL ESOP 2026 to eligible employees including KMP. Options vest over 36 months at an exercise price of Rs 10 per share.
- Execution
- 36 months vesting from grant date; exercisable within 8 months of vesting